
Christine Leonard, CNS Oncology shares her experience of managing men’s care on novel ARI’s for non-metastatic castrate resistant prostate cancer. She addresses QOL, Fear of progression, side effect management & monitoring PSA on treatment.
This podcast has been supported by BAYER.
Resources:
Macmillan Website https://www.macmillan.org.uk/cancer-information-and-support
Irish Cancer Society https://www.cancer.ie/
Cancer Research UK https://www.cancerresearchuk.org/